Method for topical treatment of scars with protein kinase C inhibitors
AssigneeWilson T Crandall
InventorWilson T Crandall
Life of this patent
Estimating the term…
Abstract
This invention relates to the topical treatment of keloids, hypertrophic scars and burn scars by the use of a selected protein kinase c inhibitor and an effective penetrating agent selected from lecithin organogel or poloxamer 407 lecithin organogel. The protein kinase c inhibitors may be selected from sphingosine, sphinganine, phytosphingosine, N-Acetylsphingosine, N-Hexanoylsphingosine, N-Octanoylsphingosine, curcumin, tetrahydrocurcumin, curcuminoids or apigenin.
Claims10
A method for treating a scar comprising the step of topically applying an effective amount of a Protein Kinase C inhibitor, wherein said Protein Kinase C inhibitor is selected from the group consisting of phytosphingosine, sphingosine, sphinganine, curcumin, tetrahydrocurcumin, curcuminoids, and apigenin and a pharmaceutically effective penetrating agent selected from the group consisting of lecithin organogel and poloxamer 407 lecithin organogel.
Dependencies are inferred from the claim text.